Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Asensus Surgical, Inc. (ASXC : AMEX)
 
 • Company Description   
Asensus Surgical Inc. is a medical device company which is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery(TM). Asensus Surgical Inc., formerly known as TransEnterix Inc., is based in RESEARCH TRIANGLE PARK, N.C.

Number of Employees: 138

 
 • Price / Volume Information   
Yesterday's Closing Price: $3.30 Daily Weekly Monthly
20 Day Moving Average: 11,041,181 shares
Shares Outstanding: 233.19 (millions)
Market Capitalization: $769.52 (millions)
Beta: 1.57
52 Week High: $6.95
52 Week Low: $0.30
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 32.53% 31.10%
12 Week 1.54% -4.90%
Year To Date 428.00% 367.53%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1 TW ALEXANDER DRIVE SUITE 160
-
DURHAM,NC 27703
USA
ph: 919-765-8400
fax: 919-765-8459
invest@transenterix.com http://www.asensus.com
 
 • General Corporate Information   
Officers
Anthony Fernando - Chief Executive Officer; President and Director
Paul A. LaViolette - Chairman
Shameze Rampertab - Executive Vice President and Chief Financial Offic
Andrea Biffi - Director
Jane H. Hsaio - Director

Peer Information
Asensus Surgical, Inc. (ABMD)
Asensus Surgical, Inc. (DMDS)
Asensus Surgical, Inc. (CPWY.)
Asensus Surgical, Inc. (EQUR)
Asensus Surgical, Inc. (ECIA)
Asensus Surgical, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 04367G103
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/21
Next Expected EPS Date: 08/04/21
Share - Related Items
Shares Outstanding: 233.19
Most Recent Split Date: 12.00 (0.08:1)
Beta: 1.57
Market Capitalization: $769.52 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.06 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.27 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/21  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 3.73
Price/Cash Flow: -
Price / Sales: 165.13
EPS Growth
vs. Year Ago Period: 85.37%
vs. Previous Quarter: 33.33%
Sales Growth
vs. Year Ago Period: 247.17%
vs. Previous Quarter: 88.00%
ROE
03/31/21 - -45.91
12/31/20 - -70.92
09/30/20 - -83.74
ROA
03/31/21 - -39.01
12/31/20 - -55.74
09/30/20 - -64.94
Current Ratio
03/31/21 - 19.18
12/31/20 - 3.31
09/30/20 - 3.24
Quick Ratio
03/31/21 - 18.00
12/31/20 - 2.33
09/30/20 - 2.30
Operating Margin
03/31/21 - -958.56
12/31/20 - -1,397.51
09/30/20 - -1,855.68
Net Margin
03/31/21 - -1,288.65
12/31/20 - -1,866.82
09/30/20 - -2,149.15
Pre-Tax Margin
03/31/21 - -1,307.10
12/31/20 - -1,915.84
09/30/20 - -2,220.35
Book Value
03/31/21 - 0.88
12/31/20 - 0.53
09/30/20 - 0.62
Inventory Turnover
03/31/21 - 0.61
12/31/20 - 0.50
09/30/20 - 1.47
Debt-to-Equity
03/31/21 - 0.00
12/31/20 - 0.03
09/30/20 - 0.04
Debt-to-Capital
03/31/21 - 0.17
12/31/20 - 2.51
09/30/20 - 3.92
 

Powered by Zacks Investment Research ©